YUMACHomo sapiens (Human)Cancer cell line

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_A745
SpeciesHomo sapiens (Human)
Tissue SourceThigh, hypodermis[UBERON:UBERON_0002072]

Disease Information

DiseaseCutaneous melanoma

DepMap Information

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleBRAFp.Val600Lys (c.1798_1799delGTinsAA)Heterozygous-from parent cell line YUSIT1

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11,12
D13S317
10
D16S539
11
D18S51
16,17
D21S11
30
D3S1358
15
D5S818
12
D7S820
9
D8S1179
10,12
FGA
21
Penta D
12,13
Penta E
7,12
TH01
6
TPOX
12
vWA
17,19

Publications

Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.

Schlessinger J., Lifton R.P., Halaban R.

Nat. Genet. 47:996-1002(2015).

Integrated analysis of tumor samples sheds light on tumor heterogeneity.

Kluger Y.

Yale J. Biol. Med. 85:347-361(2012).

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.

Lifton R.P., Schlessinger J., Boggon T.J., Halaban R.

Nat. Genet. 44:1006-1014(2012).

Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.

Xu F., Li P.-N., Halaban R., Kluger Y.

BMC Genomics 12:230.1-230.14(2011).

MicroRNA signatures differentiate melanoma subtypes.";

Krauthammer M., Tuck D., Slack F.J., Weidhaas J.B.

Cell Cycle 10:1845-1852(2011).

PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells.

Krauthammer M., McCusker J.P., Kluger Y., Sznol M.

Pigment Cell Melanoma Res. 23:190-200(2010).